BSE filing, NSE: CLEDUCATE. Summary written from the filing by ALFA Finder's alert engine.
CL Educate Ltd: key numbers
- Share price
- ₹49.00
- Market cap
- ₹265.7 Cr
- Revenue (annual)
- ₹548.1 Cr
- Net profit (annual)
- ₹-25.85 Cr
- P/E (TTM)
- -11.3×Sector 34.1×
- Promoter holding
- 51.72%-0.06% QoQ
- FII holding
- 7.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from CL Educate Ltd
All →CL Educate Annual General Meeting
CL Educate filed minutes of its 30th AGM held on 29 September 2026. Members passed all ordinary and special resolutions, including financial statement adoption and director re-appointments.
CL Educate Board Meeting Date
CL Educate intimated a Board meeting on November 3, 2026, to consider Q1/H1 FY27 results and a proposed NCD private placement for refinancing acquisition financing.
CL Educate Management Change
Mr. Yatrik Vin has resigned as a Non-Executive Independent Director of CL Educate Limited, effective October 19, 2026, citing personal and professional commitments.
CL Educate Acquisition
CL Educate's board approved amalgamating its wholly owned subsidiary DEXIT Global Limited into the parent company. No cash or share consideration is involved in the restructuring.
CL Educate Credit Rating
ICRA has assigned a credit rating of [ICRA] BBB (Stable) to CL Educate Limited and its material subsidiary, DEXIT Global Ltd.
CL Educate Other Announcement
CL Educate Limited submitted the certificate under SEBI Regulation 74(5) for the quarter ended September 30, 2026, as received from its registrar, KFin Technologies Limited.
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr